Serin Gediz Murat, Ciprut Ayça, Baylançiçek Serdar, Sari Murat, Akdaş Ferda, Tutkun Alper
Marmara University School of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Istanbul, Turkey.
Otol Neurotol. 2007 Aug;28(5):605-8. doi: 10.1097/mao.0b013e318057792f.
To analyze the ototoxicity of Burow solution as an otologic preparation.
Burow solution has been used for years in the treatment of acute or chronic otitis externa and chronic suppurative otitis media. This acidic solution has antibacterial and antiedematous properties. Ototoxic effect of Burow solution has not been known, so the current study was designed to observe the ototoxic effect of Burow solution experimentally.
Experiments were performed in 32 young, male albino guinea pigs (weight, 450-550 g). Twenty animals in the experimental group were divided into 2 groups of 10 animals each. The first group received 13% Burow solution (13% aluminum subacetate), and the second received 4% Burow solution (4% aluminum subacetate). Twelve animals in the control group were divided into 2 groups of 6 animals each. The first group received gentamicin (40 mg/mL; ototoxic control), and the second received saline solution (negative control). Under general anesthesia, pretreatment auditory brainstem responses (ABRs) from the right ear were obtained from the animals in all groups. The right tympanic membranes were widely perforated, and a small piece of Gelfoam was applied to the middle ear. Ear solutions at concentrations of 0.1 mL were applied through transcanal approach to the middle ear twice a day in 10 days. Under general anesthesia, the Gelfoam was removed from the right middle ear, and posttreatment ABRs were obtained 14 days later after the initial time in all groups.
Baseline ABR results were normal in right ears of all animals tested. Animals undergoing placement of Gelfoam with either 13% Burow solution, 4% Burow solution, or saline in the middle ear showed no changes in ABR threshold. The gentamicin group showed significant change in the ABR threshold.
Burow solution was considered to be an effective and safe otologic preparation.
分析布罗溶液作为一种耳科制剂的耳毒性。
布罗溶液多年来一直用于治疗急慢性外耳道炎和慢性化脓性中耳炎。这种酸性溶液具有抗菌和消肿特性。布罗溶液的耳毒性作用尚不明确,因此本研究旨在通过实验观察布罗溶液的耳毒性作用。
实验选用32只年轻雄性白化豚鼠(体重450 - 550克)。实验组的20只动物分为两组,每组10只。第一组接受13%布罗溶液(13%次醋酸铝),第二组接受4%布罗溶液(4%次醋酸铝)。对照组的12只动物分为两组,每组6只。第一组接受庆大霉素(40毫克/毫升;耳毒性对照),第二组接受生理盐水(阴性对照)。在全身麻醉下,获取所有组动物右耳的预处理听性脑干反应(ABR)。将右鼓膜广泛穿孔,并在中耳放置一小片明胶海绵。在10天内,通过经耳道途径每天两次向中耳施加浓度为0.1毫升的耳用溶液。在全身麻醉下,从右中耳取出明胶海绵,在初始时间14天后获取所有组的治疗后ABR。
所有受试动物右耳的基线ABR结果均正常。在中耳放置含13%布罗溶液、4%布罗溶液或生理盐水的明胶海绵的动物,其ABR阈值无变化。庆大霉素组的ABR阈值有显著变化。
布罗溶液被认为是一种有效且安全的耳科制剂。